Global Hypertension Drugs Market Status and Outlook 2018-2025

August 2018 | 147 pages | ID: GEC36570571EN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application / End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Novartis
• Daiichi Sankyo
• Actelion Pharmaceuticals
• Boehringer Ingelheim
• Sanofi
• Pfizer
• Actelion Pharmaceuticals
• Bayer
• Johnson & Johnson
• Merck

Market by Type

• Systemic hypertension drugs
• Pulmonary hypertension drugs

Market by Application

• Drugstore
• Hospital
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Hypertension Drugs Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Systemic hypertension drugs
  3.1.2 Pulmonary hypertension drugs
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Drugstore
  4.1.2 Hospital
  4.1.3 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Systemic hypertension drugs Production by Region
    6.1.1.2 Pulmonary hypertension drugs Production by Region
  6.1.2 Production by Application
    6.1.2.1 Drugstore Production by Region
    6.1.2.2 Hospital Production by Region
    6.1.2.3 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Systemic hypertension drugs Demand by Region
    6.2.1.2 Pulmonary hypertension drugs Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Drugstore Demand by Region
    6.2.2.2 Hospital Demand by Region
    6.2.2.3 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Novartis
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Daiichi Sankyo
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Actelion Pharmaceuticals
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Boehringer Ingelheim
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Sanofi
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Pfizer
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Actelion Pharmaceuticals
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Bayer
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Johnson & Johnson
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 Merck
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Hypertension Drugs Industry Dynamics & Regulations List
Table Global Hypertension Drugs Sales Revenue, Cost and Margin, 2015-2018E
Table Global Hypertension Drugs Market Status by Type 2015-2018E, in USD Million
Table Global Hypertension Drugs Market Status by Application 2015-2018E, in USD Million
Table Global Hypertension Drugs Market Status by Application 2015-2018E, in Volume
Table Global Hypertension Drugs Market by Region 2015-2018E, in USD Million
Table Global Hypertension Drugs Market Share by Region in 2018, in USD Million
Table Global Hypertension Drugs Market by Region 2015-2018E, in Volume
Table Global Hypertension Drugs Market Share by Region in 2018, in Volume
Table Systemic hypertension drugs Production Value by Region 2015-2018E, in USD Million
Table Systemic hypertension drugs Production Volume by Region 2015-2018E, in Volume
Table Pulmonary hypertension drugs Production Value by Region 2015-2018E, in USD Million
Table Pulmonary hypertension drugs Production Volume by Region 2015-2018E, in Volume
Table Drugstore Production Value by Region 2015-2018E, in USD Million
Table Drugstore Production Volume by Region 2015-2018E, in Volume
Table Hospital Production Value by Region 2015-2018E, in USD Million
Table Hospital Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Systemic hypertension drugs Market Size by Region 2015-2018E, in USD Million
Table Systemic hypertension drugs Market Size by Region 2015-2018E, in Volume
Table Pulmonary hypertension drugs Market Size by Region 2015-2018E, in USD Million
Table Pulmonary hypertension drugs Market Size by Region 2015-2018E, in Volume
Table Drugstore Market Size by Region 2015-2018E, in USD Million
Table Drugstore Market Size by Region 2015-2018E, in Volume
Table Hospital Market Size by Region 2015-2018E, in USD Million
Table Hospital Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalHypertension Drugs Forecast by Type 2019F-2025F, in USD Million
Table Hypertension Drugs Forecast by Type 2019F-2025F, in Volume
Table Hypertension Drugs Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Hypertension Drugs Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Hypertension Drugs Market Forecast by Region 2019F-2025F, in USD Million
Table Hypertension Drugs Market Forecast by Region 2019F-2025F, in Volume
Table Novartis Information
Table Hypertension Drugs Sales, Cost, Margin of Novartis
Table Daiichi Sankyo Information
Table Hypertension Drugs Sales, Cost, Margin of Daiichi Sankyo
Table Actelion Pharmaceuticals Information
Table Hypertension Drugs Sales, Cost, Margin of Actelion Pharmaceuticals
Table Boehringer Ingelheim Information
Table Hypertension Drugs Sales, Cost, Margin of Boehringer Ingelheim
Table Sanofi Information
Table Hypertension Drugs Sales, Cost, Margin of Sanofi
Table Pfizer Information
Table Hypertension Drugs Sales, Cost, Margin of Pfizer
Table Actelion Pharmaceuticals Information
Table Hypertension Drugs Sales, Cost, Margin of Actelion Pharmaceuticals
Table Bayer Information
Table Hypertension Drugs Sales, Cost, Margin of Bayer
Table Johnson & Johnson Information
Table Hypertension Drugs Sales, Cost, Margin of Johnson & Johnson
Table Merck Information
Table Hypertension Drugs Sales, Cost, Margin of Merck
Table Global Hypertension Drugs Sales Revenue by Company 2015-2017, in USD Million
Table Global Hypertension Drugs Sales Volume by Company 2015-2017, in Volume
Table Global Hypertension Drugs Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Hypertension Drugs Picture
Figure Hypertension Drugs Industry Chain Diagram
Figure Global Hypertension Drugs Sales Revenue 2015-2018E, in USD Million
Figure Global Hypertension Drugs Sales Volume 2015-2018E, in Volume
Figure Global Hypertension Drugs Market Status by Type 2015-2018E, in Volume
Figure North America Hypertension Drugs Market Size and Growth 2015-2018E, in USD Million
Figure North America Hypertension Drugs Market Size and Growth 2015-2018E, in Volume
Figure Europe Hypertension Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Europe Hypertension Drugs Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Hypertension Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Hypertension Drugs Market Size and Growth 2015-2018E, in Volume
Figure South America Hypertension Drugs Market Size and Growth 2015-2018E, in USD Million
Figure South America Hypertension Drugs Market Size and Growth 2015-2018E, in Volume
Figure Middle East Hypertension Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Hypertension Drugs Market Size and Growth 2015-2018E, in Volume
Figure Africa Hypertension Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Africa Hypertension Drugs Market Size and Growth 2015-2018E, in Volume
Figure Global Hypertension Drugs Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Hypertension Drugs Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Hypertension Drugs Sales Price Forecast 2019F-2025F
Figure Global Hypertension Drugs Gross Margin Forecast 2019F-2025F
Figure Global Hypertension Drugs Sales Revenue by Company in 2018, in USD Million
Figure Global Hypertension Drugs Price by Company in 2018
Figure Global Hypertension Drugs Gross Margin by Company in 2018